No Data
No Data
No Data
No Data
No Data
東陽光長江藥業:年度報告 2023
Futu NewsApr 26 22:50 · Announcements
Changes in Hong Kong stocks | Dongyangguang Changjiang Pharmaceutical (01558) is now up more than 3%, and the procurement price of insulin is more moderate. The company plans to win the bid for 5 products
Dongyangguang Changjiang Pharmaceutical (01558) is now up more than 3%. As of press release, it is up 3.15% to HK$12.46, with a turnover of HK$18.895 million.
Zhitong FinanceApr 25 14:40
Express News | Insulin collection continues at the procurement site: only 1 minute away from the highest price and the lowest price
BreakingsApr 23 20:41
Express News | National Health Insurance Administration: Nine batches of state-organized drugs collected domestically produced generic drugs, accounting for 96%
BreakingsApr 11 11:15
Accelerating the integration of obstetrics and medicine! How to deal with the “two ends” problem during the differentiation period of pharmaceutical innovation? Industry figures predict future internal volume reduction
① The 7th Pharmaceutical Innovation Ecology Conference (2024 Xipai Conference) with the theme of “Reconstructing R&D and Clinical Value Transformation Ecology through the Differentiation Period” opened in Zhangjiang, Shanghai. ② How to achieve original innovation with high quality and high value, and how to efficiently commercialize post-marketing products and achieve clinical value are the focus of this conference. ③ Many participants made a judgment that domestic pharmaceutical companies will reduce internal volume in the future.
cls.cnApr 10 22:19
Innovative drugs continue to warm up! Joint policies in many places catalyze the strengthening of the pharmaceutical sector in Hong Kong stocks
Recently, support policies for the innovative pharmaceutical industry have been issued in many places, bringing a new market catalyst to the currently relatively deserted pharmaceutical stocks. The Hong Kong stock pharmaceutical sector is also active today.
cls.cnApr 9 14:33
No Data
No Data